In discussing FDA’s adverse event monitoring, Makary also seemed to falsely imply the agency did not fully investigate the myocarditis signal with COVID-19 vaccines.
US Food and Drug Administration Commissioner Martin Makary is considering combining all of the agency’s adverse event reporting systems into...
Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.
HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.
Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.
Jim O’Neill recently was CEO of age-related diseases group SENS Research Foundation. After serving in HHS from 2002 to 2008, he became a managing director of Clarium Capital global investment fund and was Thiel Foundation CEO, funding nonprofits that promote technology.
